Hillsdale Investment Management Inc. Pacira Bio Sciences, Inc. Transaction History
Hillsdale Investment Management Inc.
- $1.13 Billion
- Q1 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 145,400 shares of PCRX stock, worth $3.06 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
145,400
Previous 134,000
8.51%
Holding current value
$3.06 Million
Previous $4.52 Million
6.04%
% of portfolio
0.37%
Previous 0.38%
Shares
6 transactions
Others Institutions Holding PCRX
# of Institutions
287Shares Held
48.7MCall Options Held
156KPut Options Held
623K-
Black Rock Inc. New York, NY7.91MShares$166 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$108 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.91MShares$40.3 Million0.55% of portfolio
-
State Street Corp Boston, MA1.9MShares$40.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$39.6 Million0.09% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $965M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...